WY
39
2
ETN
65
-2
CVX
37
6
AKAM
56
-3
IVZ
62
-6
TGNA
48
-2
AME
65
2
OMC
59
8
MET
60
2
EQIX
59
5
MCO
65
3
ORCL
37
3
GILD
47
-2
ROP
50
3
KO
44
-2
CAG
37
3
MTB
69
-2
DLTR
66
4
WFC
69
-2
AVB
30
-4
WY
39
2
ETN
65
-2
CVX
37
6
AKAM
56
-3
IVZ
62
-6
TGNA
48
-2
AME
65
2
OMC
59
8
MET
60
2
EQIX
59
5
MCO
65
3
ORCL
37
3
GILD
47
-2
ROP
50
3
KO
44
-2
CAG
37
3
MTB
69
-2
DLTR
66
4
WFC
69
-2
AVB
30
-4
Financhill
Back

Builders FirstSource, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
46

BLDR
Builders FirstSource, Inc.

Last Price:
$106.67
Seasonality Move:
13.36%
Sell
37

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.86
Seasonality Move:
8.64%
Sell
46
Builders FirstSource, Inc. (BLDR) is a Sell

Is Builders FirstSource, Inc. a Buy, Sell or Hold?

  • The current Builders FirstSource, Inc. [BLDR] share price is $110.01. The Score for BLDR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.38. The Score for RARE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLDR Stock Price Chart

What is Builders FirstSource, Inc.'s stock price today?

  • The Builders FirstSource, Inc. share price today is $110.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 49.57 Sell
Chaikin Money Flow: -1775334 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.42 - 113.08) Buy
Bollinger Bands (100): (111.96 - 137.62) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.84 Buy
Relative Strength Index (14 RSI): 62.77 Buy
Chaikin Money Flow: -414275 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.73 - 34.81) Buy
Bollinger Bands (100): (28.38 - 33.4) Buy

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.71 Sell
20-day SMA: 106.08 Buy
50-day SMA: 115.32 Sell
200-day SMA: 123.12 Sell
8-day EMA: 110.19 Sell
20-day EMA: 109.29 Buy
50-day EMA: 114.34 Sell
200-day EMA: 127.43 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.78 Buy
20-day SMA: 33.42 Buy
50-day SMA: 32.79 Buy
200-day SMA: 33.89 Buy
8-day EMA: 35.02 Buy
20-day EMA: 33.96 Buy
50-day EMA: 32.94 Buy
200-day EMA: 34.73 Buy

Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.40 per share, and a decrease next year of $0.58 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Builders FirstSource, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):